Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gemini Therapeutics, Inc.

1.35
0.0000
Volume:- -
Turnover:85.98K
Market Cap:5.85M
PE:-0.13
High:1.35
Open:1.35
Low:1.35
Close:1.35
Loading ...
OverviewCompanyNewsFilings

Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation

Dow Jones
·
27 Dec 2022

BRIEF-Disc Medicine Receives FDA Orphan Drug Designation For Bitopertin

Reuters
·
27 Dec 2022

Apartment Investment and Gemini Therapeutics Stock See Action From Activist Investors -- Barrons.com

Dow Jones
·
05 Nov 2022

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Gemini Therapeutics, Inc. (Nasdaq - GMTX), CyberOptics Corporation (Nasdaq – CYBE), STORE Capital Corporatio

StreetInsider
·
20 Sep 2022

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Centric Financial Corporation (OTC - CFCX), Gemini Therapeutics, Inc. (Nasdaq - GMTX), BBQ Holdings, Inc. (Nas

StreetInsider
·
02 Sep 2022

GEMINI THERAPEUTICS, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of GMTX and Encourages Investors to Contact the Firm

StreetInsider
·
13 Aug 2022

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial

Benzinga
·
10 Aug 2022

Gemini Therapeutics Sets Reverse Merger With Disc Medicine

Dow Jones
·
10 Aug 2022

BRIEF-Gemini Therapeutics And Disc Medicine Announce Merger Agreement

Reuters
·
10 Aug 2022

Analyst Rate

 
 
 
 

Corporate Actions

Symbol Change
Dec 30, 2022 IRON
Split&Reverse Split
Dec 30, 2022 10 for 1
Financial Report Announcement
Mar 10, 2022 Pre-Market
Financial Report Announcement
Aug 12, 2021
Financial Report Announcement
May 13, 2021

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.35
Current
-3.90
Sector Average
56.48%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.35
Maximum
-0.77
+1 STD
1.04
Minimum
-22.08
-1 STD
-8.84
Average
-3.90

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.